Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells

Kuang,Jing; Wang,Ya-Lan; Xiao,Ming; Tang,Yi; Chen,Wen‑Wen; Song,Guang-Lin; Yang,Xi; Li,Ming

doi:10.3892/or.2014.3100

Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells

Authors:
- Jing Kuang
- Ya-Lan Wang
- Ming Xiao
- Yi Tang
- Wen‑Wen Chen
- Guang-Lin Song
- Xi Yang
- Ming Li
View Affiliations

Affiliations: Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: March 20, 2014 https://doi.org/10.3892/or.2014.3100
Pages: 2335-2343

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arginine-specific ADP-ribosyltransferase 1 (ART1) and poly(ADP-ribose) polymerase-1 (PARP-1) are both post‑translational modification proteins. Inhibition of PARP1 induces apoptosis in cancer cells, and ART1 regulates RhoA which promotes apoptosis in hepatic cancer cells when inhibited. However, the interaction of ART1 and PARP-1 on the effect of apoptosis has not yet been elucidated. In the present study, lentiviral vector-mediated ART1-cDNA was transfected into CT26 cells, and the apoptosis rate was detected by flow cytometric assay and Hoechst 33342 staining. Relevant factors were detected by reverse transcriptase-PCR and western blotting. The results showed that the apoptosis rate in the ART1-cDNA CT26 cells treated with PARP-1 inhibitor 5-aminoisoquinoline (5-AIQ) and cisplatin increased, when compared with the ART1-cDNA CT26 cells treated with cisplatin only or the untreated ART1-cDNA CT26 cells. Further studies have shown that PARP-1 is in the downstream of ART1, and plays a role in ART1-mediated CT26 cell apoptosis through the ROCK1/NF-κB/PARP-1 pathway when induced by cisplatin. We also found that in cisplatin-treated cells, activated caspase 3 cleaved PARP-1 and the decreased level of PARP-1 in turn decreased the expression of nuclear factor (NF)-κB, Cox-2 and increased caspase 3, resulting in the enhanced ability of ART1 to regulate CT26 cell apoptosis. Our research provides initial sight into the synergistic effect of ART1 and PARP-1 on apoptosis induced by cisplatin in murine colon carcinoma CT26 cells.

View Figures

View References

1	Hassa PO, Haenni SS, Elser M and Hottiger MO: Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev. 70:789–829. 2006. View Article : Google Scholar : PubMed/NCBI
2	Otto H, Reche PA, Bazan F, Dittmar K, Haag F and Koch-Nolte F: In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs). BMC Genomics. 6:1392005. View Article : Google Scholar
3	Ueda K and Hayaishi O: ADP-ribosylation. Annu Rev Biochem. 54:73–100. 1985. View Article : Google Scholar
4	Corda D and Di Girolamo M: Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci STKE. 2002:pe532002.PubMed/NCBI
5	Corda D and Di Girolamo M: Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953–1958. 2003. View Article : Google Scholar : PubMed/NCBI
6	Zhao Z, Gruszczynska-Biegala J and Zolkiewska A: ADP-ribosylation of integrin α7 modulates the binding of integrin α7β1 to laminin. Biochem J. 385:309–317. 2005.
7	Okazaki IJ, Zolkiewska A, Nightingale MS and Moss J: Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. Biochemistry. 33:12828–12836. 1994. View Article : Google Scholar : PubMed/NCBI
8	Zolkiewska A, Nightingale MS and Moss J: Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci USA. 89:11352–11356. 1992. View Article : Google Scholar : PubMed/NCBI
9	Paone G, Stevens LA, Levine RL, et al: ADP-ribosyltransferase-specific modification of human neutrophil peptide-1. J Biol Chem. 281:17054–17060. 2006. View Article : Google Scholar : PubMed/NCBI
10	Yau L, Litchie B, Thomas S, Storie B, Yurkova N and Zahradka P: Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem. 270:101–110. 2003. View Article : Google Scholar
11	Gilcrease MZ: Integrin signaling in epithelial cells. Cancer Lett. 247:1–25. 2007. View Article : Google Scholar
12	Takeba Y, Matsumoto N, Watanabe M, et al: The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells. Cancer Chemother Pharmacol. 69:1545–1555. 2012. View Article : Google Scholar : PubMed/NCBI
13	Hippenstiel S, Schmeck B, N’Guessan PD, et al: Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 283:L830–L838. 2002. View Article : Google Scholar : PubMed/NCBI
14	Kirkland JB: Poly ADP-ribose polymerase-1 and health. Exp Biol Med. 235:561–568. 2010. View Article : Google Scholar : PubMed/NCBI
15	Xu JX, Wang YL, Tang Y and Xiong W: Effect of ART1 gene silencing by RNA interference on the proliferation of mouse colon carcinoma cells and its possible mechanism. TUMOR. 32:949–954. 2012.
16	Li Q, Li M, Wang YL, et al: RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway. Cell Physiol Biochem. 29:361–372. 2012. View Article : Google Scholar : PubMed/NCBI
17	Fauzee NJ, Li Q, Wang YL and Pan J: Silencing poly (ADP-ribose) glycohydrolase (PARG) expression inhibits growth of human colon cancer cells in vitro via PI3K/Akt/NFκ-B pathway. Pathol Oncol Res. 18:191–199. 2012.PubMed/NCBI
18	Fauzee NJ, Pan J and Wang YL: PARP and PARG inhibitors - new therapeutic targets in cancer treatment. Pathol Oncol Res. 16:469–478. 2010. View Article : Google Scholar : PubMed/NCBI
19	Ye K: PARP inhibitor tilts cell death from necrosis to apoptosis in cancer cells. Cancer Biol Ther. 7:942–944. 2008. View Article : Google Scholar : PubMed/NCBI
20	Tang Y, Wang YL, Yang L, et al: Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma. Int J Mol Med. 32:130–136. 2013.PubMed/NCBI
21	Furuya K, Ozaki T, Hanamoto T, et al: Stabilization of p73 by nuclear IκB kinase-α mediates cisplatin-induced apoptosis. J Biol Chem. 282:18365–18378. 2007.
22	Ohnishi K, Ota I, Takahashi A, Yane K, Matsumoto H and Ohnishi T: Transfection of mutant p53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck. Apoptosis. 7:367–372. 2002. View Article : Google Scholar : PubMed/NCBI
23	van Houdt WJ, Hoogwater FJ, de Bruijn MT, et al: Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation. Neoplasia. 12:443–452. 2010.PubMed/NCBI
24	Benitah SA, Valerón PF and Lacal JC: ROCK and nuclear factor-κB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell. 14:3041–3054. 2003.
25	Zhang Z, Lai GH and Sirica AE: Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation. Hepatology. 39:1028–1037. 2004. View Article : Google Scholar : PubMed/NCBI
26	Lax AJ and Thomas W: How bacteria could cause cancer: one step at a time. Trends Microbiol. 10:293–299. 2002. View Article : Google Scholar : PubMed/NCBI
27	Nicholson DW and Thornberry NA: Caspases: killer proteases. Trends Biochem Sci. 22:299–306. 1997. View Article : Google Scholar
28	Yin MJ, Yamamoto Y and Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature. 396:77–80. 1998.
29	Cai L, Threadgill MD, Wang Y and Li M: Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells. Pathol Oncol Res. 15:323–328. 2009. View Article : Google Scholar : PubMed/NCBI
30	Chiti F, Stefani M, Taddei N, Ramponi G and Dobson CM: Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 424:805–808. 2003. View Article : Google Scholar : PubMed/NCBI
31	Hassa PO and Hottiger MO: The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell Mol Life Sci. 59:1534–1553. 2002.PubMed/NCBI
32	Ratnam K and Low JA: Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Clin Cancer Res. 13:1383–1388. 2007. View Article : Google Scholar : PubMed/NCBI
33	Jagtap P and Szabó C: Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. 4:421–440. 2005. View Article : Google Scholar : PubMed/NCBI
34	Schreiber V, Dantzer F, Ame JC and De Murcia G: Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 7:517–528. 2006. View Article : Google Scholar : PubMed/NCBI
35	Li J and Yuan J: Caspases in apoptosis and beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
36	Kim JW, Kim K, Kang K and Joe CO: Inhibition of homodimerization of poly(ADP-ribose) polymerase by its C-terminal cleavage products produced during apoptosis. J Biol Chem. 275:8121–8125. 2000. View Article : Google Scholar : PubMed/NCBI
37	Kim JW, Won J, Sohn S and Joe CO: DNA-binding activity of the N-terminal cleavage product of poly(ADP-ribose) polymerase is required for UV mediated apoptosis. J Cell Sci. 113:955–961. 2000.PubMed/NCBI
38	D’Ambrosio SM, Gibson-D’Ambrosio RE, Brady T, Oberyszyn AS and Robertson FM: Mechanisms of nitric oxide-induced cytotoxicity in normal human hepatocytes. Environ Mol Mutagen. 37:46–54. 2001.PubMed/NCBI
39	Chaitanya GV, Steven AJ and Babu PP: PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 8:312010. View Article : Google Scholar : PubMed/NCBI
40	Soldani C and Scovassi A: Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis. 7:321–328. 2002. View Article : Google Scholar : PubMed/NCBI
41	Virág L and Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 54:375–429. 2002.